Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death.

ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death. N Engl J Med. 2013 Aug 08; 369(6):529-39.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.